Small bowel adenocarcinoma in a young male

A case report

Authors

  • Hanan Mesfer Alghamdi MBBS, MD, SB-Surg, FICS, Hepatobiliary & Multiorgan Transplant Surgeon, Assistant Professor, King Fahad Hospital of the University, Department of Surgery, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia

Keywords:

Adenocarcinoma of the small bowel, third part of the duodenum, segmental resection

Abstract

Introduction: Adenocarcinoma of the third part of the duodenum is a rare type of tumor that has challenges in its diagnosis and management. Segmental resection with pancreatic sparing is a safe and accepted choice for the surgical intervention of this type of cancer. Case Presentation: A 33-year-old male presented with a 3-week history of symptoms of gastric outlet obstruction with anemia and weight loss. Upon investigating the patient with computed tomography and esophagogastroduodenoscopy, he was found to have an adenocarcinoma that involved the third part of the duodenum. The patient underwent segmental resection of the third and fourth part of the duodenum with pancreatic sparing. He had a smooth postoperative course. The pathological evaluation shows a 3 cm moderately differentiated adenocarcinoma with free margins. Six out of thirteen lymph nodes were having metastasis. The patient developed a soft tissue recurrence 18 months after the operation. Take-away Lessons: Adenocarcinoma of the third part of the duodenum should be kept in mind in any patient presented with symptoms of gastric outlet obstruction. It can be managed safely with segmental resection avoiding the morbidity of resection of the pancreas.

References

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018; 68: 7–30. doi:

3322/caac.21442. PMID: 29313949.

Pan SY, Morrison H. Epidemiology of cancer of the small intestine. World J Gastrointest Oncol. 2011; 3:

–42. doi: 10.4251/wjgo.v3.i3.33. PMID: 21461167, PMCID: PMC3069308.

García-Molina FJ, Mateo-Vallejo F, Franco-Osorio J de D, Esteban-Ramos JL, Rivero-Henández I.

Surgical approach for tumours of the third and fourth part of the duodenum. Distal pancreas-sparing

duodenectomy. Int J Surg. 2015; 18: 143–8. doi: 10.1016/j.ijsu.2015.04.051. PMID: 25917202.

Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS. Small Bowel Cancer in the

United States. Ann Surg. 2009; 249: 63–71. doi: 10.1097/SLA.0b013e31818e4641. PMID: 19106677.

Halfdanarson TR, McWilliams RR, Donohue JH, Quevedo JF. A single-institution experience with 491

cases of small bowel adenocarcinoma. Am J Surg. 2010; 199: 797–803. doi:

1016/j.amjsurg.2009.05.037. PMID: 20609724.

Lee SY, Lee JH, Hwang DW, Kim SC, Park KM, Lee YJ. Long-term outcomes in patients with duodenal

adenocarcinoma. ANZ J Surg. 2014; 84: 970–5. doi: 10.1111/ans.12112. PMID: 23656271.

Tocchi A, Mazzoni G, Puma F, Miccini M, Cassini D, Bettelli E, et al. Adenocarcinoma of the third and

fourth portions of the duodenum: results of surgical treatment. Arch Surg. 2003; 138: 80–5. doi:

1001/archsurg.138.1.80. PMID: 12511157.

Cloyd JM, Norton JA, Visser BC, Poultsides GA. Does the extent of resection impact survival for duodenal

adenocarcinoma? Analysis of 1,611 cases. Ann Surg Oncol. 2015; 22: 573–80. doi: 10.1245/s10434-014- 4020-z. PMID: 25160736.

Dorcaratto D, Heneghan HM, Fiore B, Awan F, Maguire D, Geoghegan J, et al. Segmental duodenal

resection: Indications, surgical techniques and postoperative outcomes. J Gastrointest Surg. 2015; 19: 736–

doi: 10.1007/s11605-015-2744-0. PMID: 25595309.

Ye X, Zhang G, Chen H, Li Y. Meta-analysis of postoperative adjuvant therapy for small bowel

adenocarcinoma. PLoS One. 2018; 13: e0200204. doi: 10.1371/journal.pone.0200204. PMID: 30096150,

PMCID: PMC6086425.

Chung WC, Paik CN, Jung SH, Lee KM, Kim SW, Chang UI, et al. Prognostic factors associated with

survival in patients with primary duodenal adenocarcinoma. Korean J Intern Med. 2011; 26: 34–40. doi:

3904/kjim.2011.26.1.34. PMID: 21437160, PMCID: PMC3056253.

Kim MJ, Choi SB, Han HJ, Park PJ, Kim WB, Song TJ, et al. Clinicopathological analysis and survival

outcome of duodenal adenocarcinoma. Kaohsiung J Med Sci. 2014; 30: 254–9. doi:

1016/j.kjms.2013.12.006. PMID: 24751389.

Liang TJ, Wang BW, Liu SI, Chou NH, Tsai CC, Chen IS, et al. Number of involved lymph nodes is

important in the prediction of prognosis for primary duodenal adenocarcinoma. J Chinese Med Assoc.

; 75: 573–80. doi: 10.1016/j.jcma.2012.08.002. PMID: 23158035.

Downloads

Published

2021-12-14